Dr. Munish Luthra completed his medical school in India from Calicut Medical College, Kerala and then went on to do Internal Medicine Residency from Meerut Medical College, India, and received his MD in 2004. Subsequently, he moved to USA, where he completed second Internal Medicine residency training at the Mount Sinai School of Medicine in New York and served as Chief Resident for the academic year 2010-2011. He then pursued Critical Care Medicine fellowship at Mount Sinai School of Medicine, and Pulmonary Medicine Fellowship at Memorial Sloan Kettering Cancer Center, Cornell University in New York from 2011-2014. In July, 2014, Dr. Luthra joined Albany Medical College in New York as Assistant Professor of Medicine in the Division of Pulmonary & Critical Care Medicine. Here, he also served as Medical Director of Pulmonary Module for the second year medical students and played a key role in developing the Division’s lung cancer Screening Program and Pleural service. He also served as core-teaching faculty for the Internal Medicine Residency Program at Albany Med. Dr. Luthra treats patients with general pulmonary conditions, such as obstructive airways diseases like COPD and Asthma, interstitial lung disease and lung cancer.He joined Emory School of Medicine in February 2016 in the medical education and service track. Besides his clinical work, Dr. Luthra has strong interest in medical education and administration. Currently, he serves on the panel of judges and moderators for the American Medical Association and the American College of Chest Physicians (CHEST). He has served as the co-editor for the American Thoracic Society’s Pulmonary Core Curriculum and MOC module developer in 2014, and Organizational reviewer for the recently published CHEST guidelines on the “Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults, August, 2014. Dr. Luthra was recently awarded “Gold Apple Award” for excellence in teaching by Dept. of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

His main areas of interest and expertise include lung cancer, chemotherapy-induced pulmonary toxicity, pulmonary complications of bone marrow transplant, and smoking related lung diseases, and immunocompromised host.